About 1 result found for searched term "NEO1132" (0.129 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M45248 | NEO1132 | Epigenetic Reader Domain |
| NEO1132 is a novel, orally active dual inhibitor of BET and CBP/EP300 with antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
